IL2RA and neoplasm: After binding to IL-15Rα, IL-15 is trans-presented to the IL-2R/IL-15Rβ and -γ heterodimer expressed on effector T, B, and NK cells, thereby enhancing survival and maturation of the effector cells for killing tumor cells [26, 27].